Clinical trial
Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis
NCT03474198 is registered in ClinicalTrials.gov with University College, London as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis
- Lead sponsor
- University College, London
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- March 21, 2018
- Completion date
- January 20, 2022
- Enrollment
- 675 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.